Search results
Moderna's Bancel defends COVID-19 vaccine price at Sanders hearing
Yahoo Finance· 1 year agoModerna's CEO Stéphane Bancel faced off with Sen. Bernie Sanders and others of the Senate HELP...
Moderna's billionaire CEO reaped nearly $400 million last year. He also got a raise.
Washington Post via Yahoo News· 12 months agoStéphane Bancel, chief executive of Moderna, had a good year in 2022, exercising stock options that...
Fact check: Post misinterprets Moderna CEO Stephane Bancel's comments on vaccine supply
USA TODAY via Yahoo News· 1 year agoThe claim: Moderna CEO admits company produced 100,000 COVID-19 vaccine doses before pandemic A Feb....
Moderna will break even in 2026: CEO Stéphane Bancel
Yahoo Finance via AOL· 6 months agoModerna (MRNA) missed Wall Street expectations in the third quarter earnings report released Thursday, as it continues rightsizing the company and...
Democrats blast Moderna CEO over plans to quadruple price of COVID-19 vaccine
The Hill via Yahoo News· 1 year agoDemocratic senators lashed out at Moderna CEO Stéphane Bancel in a Thursday hearing over his...
Moderna CEO says he'll give away most of his estimated $4.1 billion fortune
Business Insider via Yahoo News· 2 years agoStephane Bancel, CEO of Moderna.Nancy Lane/MediaNews Group/Boston Herald Moderna's CEO said he plans...
Moderna’s CEO shares what it was like to leap from pre-revenue startup to household name and Fortune...
Fortune via Yahoo Finance· 12 months agoOn this week’s episode of Fortune‘s Leadership Next podcast, co-hosts Alan Murray and Michal Lev-Ram...
Moderna: Stock soars on cancer vaccine data, CEO Bancel takes on commercial role
Yahoo Finance via AOL· 4 months agoShares of Moderna soared around 14% on Thursday on the news that a personalized cancer vaccine,...
Moderna's CEO To Appear Before Senate On Quadrupling COVID-19 Vaccine Prices
Benzinga via Yahoo Finance· 1 year agoModerna Inc's (NASDAQ: MRNA) CEO, Stéphane Bancel, will testify next month on its plans to raise the...
Moderna Just Took a Step Closer to Its Product Launch Goal. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 4 months agoModerna (NASDAQ: MRNA) today is known for its one and only product: the coronavirus vaccine now...